术前糖化血红蛋白、血糖状态与普通外科术后结局
结果显示已诊断和未诊断的血糖异常均与并发症、再入院或死亡风险升高独立相关,支持常规术前HbA1c筛查。
要点
- 已诊断糖尿病患者HbA1c从接近正常至极差控制,任何并发症风险逐步升高。
- 未诊断糖尿病与医疗并发症和死亡风险升高相关。
- 相当比例患者HbA1c达糖尿病范围但无糖尿病诊断。
核心结论
- 已诊断和未诊断的血糖异常在普通外科患者中高度流行,且与并发症、再入院或死亡风险升高独立相关。
主要发现
- 糖尿病患者任何并发症风险从HbA1c低于6.0%(OR 1.06;95%CI 1.00-1.11)至高于9.0%(OR 1.32;95%CI 1.25-1.39)逐步升高。
- 未诊断糖尿病与医疗并发症风险升高(OR 1.11;95%CI 1.04-1.18)和死亡风险升高(OR 1.24;95%CI 1.07-1.42)相关。
临床怎么用
- 支持常规术前HbA1c筛查,以识别未诊断糖尿病并优化手术风险评估。
- 对血糖异常患者采取个体化血糖管理策略,以减少并发症并改善围术期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Dysglycemia is increasingly recognized as a major contributor to adverse surgical outcomes. However, the clinical utility of preoperative hemoglobin A1C (HbA1c) screening in general surgery remains unclear. OBJECTIVE: To determine whether elevated HbA1c is associated with increased 30-day postoperative complications, readmissions, and mortality in patients undergoing general surgery procedures. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used the American College of Surgeons National Surgical Quality Improvement Program database from 2021 to 2023. Multivariable logistic regression was used to evaluate associations between glycemic status and complications within 30 days after surgery. The multicenter database comprised more than 700 participating institutions worldwide, predominantly in the US. Participants included adult patients (18 years or older) undergoing general surgery procedures with available HbA1c data. EXPOSURES: Glycemic status categorized by documented diabetes diagnosis and HbA1c levels, ranging from normoglycemia to very poor glycemic control. Patients without a diagnosis but HbA1c levels higher than 6.4% (to convert to proportion of total hemoglobin, multiply by 0.01) were considered to have undiagnosed diabetes. MAIN OUTCOMES AND MEASURES: Main outcomes included occurrence of any, surgical, and medical complications, as well as readmissions, reoperations, and mortality within 30 days after surgery. RESULTS: Among 282 131 patients (mean [SD] age, 60 [15] years), 36% had diagnosed diabetes, whereas 6.4% had HbA1c values in the diabetes range but no diagnosis. In those patients with diabetes, risk of any complication increased progressively from near normal (HbA1c level <6.0%; odds ratio [OR], 1.06; 95% CI, 1.00-1.11) to very poor glycemic control (HbA1c level >9.0%; OR, 1.32; 95% CI, 1.25-1.39). Undiagnosed diabetes was also associated with higher risks of medical complications (OR, 1.11; 95% CI, 1.04-1.18) and mortality (OR, 1.24; 95% CI, 1.07-1.42). CONCLUSIONS AND RELEVANCE: Dysglycemia-both diagnosed and undiagnosed-is highly prevalent among general surgery patients and independently associated with increased risks of complications, readmissions, or mortality. A significant proportion of patients had HbA1c levels in the diabetes range, despite lacking a diabetes diagnosis. These findings support routine preoperative HbA1c screening and the adoption of individualized glycemic management strategies to optimize surgical risk assessment, reduce complications, and improve perioperative outcomes.
引用
- Schaschinger T, Niederegger T, Brandt J, et al. Preoperative Hemoglobin A1C, Glycemic Status, and Postoperative Outcomes in General Surgery. JAMA Surg. 2026. PMID: 41191374. doi:10.1001/jamasurg.2025.4706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。